Literature DB >> 12091579

Bradykinin lowers the threshold temperature for heat activation of vanilloid receptor 1.

Takeshi Sugiura1, Makoto Tominaga, Hirotada Katsuya, Kazue Mizumura.   

Abstract

Bradykinin (BK) is an inflammatory mediator that plays a pivotal role in pain and hyperalgesia to heat in inflamed tissues by exciting nociceptors and sensitizing them to heat through activation of protein kinase C (PKC). It has been suggested that the capsaicin receptor (VR1), a nociceptor-specific cation channel sensitive to noxious heat, protons, and capsaicin, is a channel that is modified by BK in these effects. In this study, we examined how BK modulates the activity of VR1. We measured VR1 currents using the patch-clamp technique in human embryonic kidney-derived (HEK293) cells expressing VR1 and B2 BK receptor. We found that BK lowered the threshold temperature for activation of VR1 currents in HEK cells down to well below the physiological body temperature in a concentration-dependent manner through PKC activation. We also demonstrated that in capsaicin-sensitive dorsal root ganglion (DRG) neurons the activation threshold of heat-induced current, which is considered to be VR-1 mediated, was lowered by BK and that this effect was also mediated by PKC. These data further support the supposition that modulation of VR1 is a mechanism for the BK-induced excitation of nociceptors and their sensitization to heat.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12091579     DOI: 10.1152/jn.2002.88.1.544

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  97 in total

1.  Implantation of tumoral XC cells induces chronic, endothelin-dependent, thermal hyperalgesia in mice.

Authors:  Ana Baamonde; Ana Lastra; Manuel F Fresno; Sara Llames; Alvaro Meana; Agustín Hidalgo; Luis Menéndez
Journal:  Cell Mol Neurobiol       Date:  2004-04       Impact factor: 5.046

Review 2.  International Union of Basic and Clinical Pharmacology. LXXVI. Current progress in the mammalian TRP ion channel family.

Authors:  Long-Jun Wu; Tara-Beth Sweet; David E Clapham
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

3.  An oral TRPV1 antagonist attenuates laser radiant-heat-evoked potentials and pain ratings from UV(B)-inflamed and normal skin.

Authors:  Klaus Schaffler; Peter Reeh; W Rachel Duan; Andrea E Best; Ahmed A Othman; Connie R Faltynek; Charles Locke; Wolfram Nothaft
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

Review 4.  TRPs and pain.

Authors:  Yi Dai
Journal:  Semin Immunopathol       Date:  2015-09-15       Impact factor: 9.623

5.  Dry eye sensitizes cool cells to capsaicin-induced changes in activity via TRPV1.

Authors:  Azusa Hatta; Masayuki Kurose; Cara Sullivan; Keiichiro Okamoto; Noritaka Fujii; Kensuke Yamamura; Ian D Meng
Journal:  J Neurophysiol       Date:  2019-04-10       Impact factor: 2.714

Review 6.  Nucleotide signaling and cutaneous mechanisms of pain transduction.

Authors:  G Dussor; H R Koerber; A L Oaklander; F L Rice; D C Molliver
Journal:  Brain Res Rev       Date:  2008-12-31

7.  Thermosensitive transient receptor potential (TRP) channel agonists and their role in mechanical, thermal and nociceptive sensations as assessed using animal models.

Authors:  A H Klein; Minh Trannyguen; Christopher L Joe; Carstens M Iodi; E Carstens
Journal:  Chemosens Percept       Date:  2015-08       Impact factor: 1.833

8.  Spinal nerve ligation in mouse upregulates TRPV1 heat function in injured IB4-positive nociceptors.

Authors:  Daniel Vilceanu; Prisca Honore; Quinn H Hogan; Cheryl L Stucky
Journal:  J Pain       Date:  2009-12-16       Impact factor: 5.820

9.  Jejunal afferent nerve sensitivity in wild-type and TRPV1 knockout mice.

Authors:  Weifang Rong; Kirk Hillsley; John B Davis; Gareth Hicks; Wendy J Winchester; David Grundy
Journal:  J Physiol       Date:  2004-08-26       Impact factor: 5.182

10.  Nociceptors lacking TRPV1 and TRPV2 have normal heat responses.

Authors:  C Jeffery Woodbury; Melissa Zwick; Shuying Wang; Jeffrey J Lawson; Michael J Caterina; Martin Koltzenburg; Kathryn M Albers; H Richard Koerber; Brian M Davis
Journal:  J Neurosci       Date:  2004-07-14       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.